Science in 3 minutes: Bleomycin induced pulmonary fibrosis mouse model
In this video, Dr. Ramesh Subbarayan from Syngene’s Discovery Biology team explains the science behind Syngene’s bleomycin-induced pulmonary fibrosis mouse model that is helping advance research in pulmonary fibrosis.
Ask the Expert: 3 big questions in Drug Product Development
Watch this video to hear our expert Purushottam Singnurkar on the key considerations in Formulation Development.
Ask the Expert: Clinical Development
Watch this video to hear our Head of Clinical Development, Chetan Tamhankar, answer three big questions related to Clinical Development, including advantages of engaging with CROs on a partnership model rather than a transactional vendor model.
Ask the Expert: Commercial Manufacturing
Watch this video to hear our expert, Subramanium Naik, answer three big questions related to manufacturing, emerging trends and more.
Ask the Expert: Top 3 questions for selecting the right Toxicology partner
In this video, our Discovery Services Head, Dr. Kenneth Barr, shares his views on the key factors your should consider when outsourcing your toxicology program.
Promoting Catalytic C-Selective Sulfonylation of Cyclopropanols against Conventional O-Sulfonylation Using Readily Available Sulfonyl Chlorides
Publication: ACS Publications
Navigating a smarter race: Lead to first-in-human studies
Learn the key strategies adopted by leading CDMO Syngene to accelerate the lead to first-in-human (FIH) journey of small molecules for clients.
How Syngene partnered with a bioengineering company to synthesize a complex, triblock copolymer to address biofouling issues
Learn how Syngene synthesized a complex polymer using the RAFT technique and delivered several kilograms of the polymer in just one month.
Leveraging High Throughput Screening services to accelerate drug discovery and development
The many applications of HTS and how it has evolved beyond lead identification and candidate optimization today.
How Syngene supported a biotech in developing a PROTAC molecule for treating cancer
Learn how Syngene successfully developed and manufactured several kilograms of a PROTAC molecule under cGMP conditions within 12 months for treating a certain type of cancer.